imidazole has been researched along with Lung Adenocarcinoma in 1 studies
imidazole: RN given refers to parent cpd
1H-imidazole : An imidazole tautomer which has the migrating hydrogen at position 1.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bhavya, K | 1 |
| Mantipally, M | 1 |
| Roy, S | 1 |
| Arora, L | 1 |
| Badavath, VN | 1 |
| Gangireddy, M | 1 |
| Dasgupta, S | 1 |
| Gundla, R | 1 |
| Pal, D | 1 |
1 other study available for imidazole and Lung Adenocarcinoma
| Article | Year |
|---|---|
Novel imidazo[1,2-a]pyridine derivatives induce apoptosis and cell cycle arrest in non-small cell lung cancer by activating NADPH oxidase mediated oxidative stress.
Topics: Adenocarcinoma of Lung; Antineoplastic Agents; Apoptosis; Carcinoma, Non-Small-Cell Lung; Cell Cycle | 2022 |